CANDACE WORTHAM: Open Payments
NPI 1902842263 · LAGRANGE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,581 in 80 payments from 18 companies in 2025. Trend: 2023 $1,329 · 2024 $2,294 · 2025 $1,581
Food & beverage: $1,581
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $342 |
| GlaxoSmithKline, LLC. | 18 | $236 |
| Regeneron Healthcare Solutions, Inc. | 7 | $185 |
| GENZYME CORPORATION | 4 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $94 |
| Verona Pharma, Inc. | 4 | $86 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $68 |
| Philips North America LLC | 3 | $64 |
| Janssen Biotech, Inc. | 3 | $64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $60 |
Products named: DUPIXENT, NUCALA, FASENRA, AIRSUPRA, Ohtuvayre, TEZSPIRE, XIFAXAN, Vest Therapy Und.
Industry payments across GA — which companies pay providers there.
